Last updated on February 2019

A Survey on Quetiapine Extended-release Tablets in Patients With Depression in Bipolar Disorder


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Endogenous depression | Bipolar Disorder | Depression
  • Age: - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Patients with depressive symptoms of bipolar disorder
  • Patients who have previously not been treated with quetiapine fumarate (immediate-release formulations of quetiapine fumarate and Bipresso Extended-Release Tablets)

Exclusion Criteria:

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.